Figure 4
Figure 4. The 5-year EFS and OS for APL patients treated with ATRA/ATO combination or each monotherapy (ATRA/chem→ATO).

The 5-year EFS and OS for APL patients treated with ATRA/ATO combination or each monotherapy (ATRA/chem→ATO).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal